Plantar Fasciitis
Conditions
Interventions
Experimental Group:Dynamic Ultrasound Evaluation + Contrast-Enhanced Ultrasound-Guided Long-Round Needle Release
Control Group:Standardized Extracorporeal Shockwave Therapy
Sponsors
People's Liberation Army Logistics Support Force 962nd Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Diagnostic Criteria Based on domestic and international clinical consensus and authoritative guidelines for plantar fasciitis, confirmed cases are identified through three dimensions: clinical symptoms, physical examination, and imaging: (1) Typical clinical symptoms: severe heel pain upon waking, aggravated pain after prolonged rest, pain relief after walking, or recurrent episodes; (2) Specialized physical examination: significant tenderness at the origin of the plantar fascia, increased fascial tension, and exacerbated pain during passive ankle dorsiflexion; (3) Ultrasound findings: localized thickening of the plantar fascia, edematous degeneration, reduced internal echogenicity, and increased local blood flow signals. 2. Inclusion Criteria (1) Age 18-65 years, any gender; (2) Meets the above diagnostic criteria for plantar fasciitis, with a disease duration of 2 weeks to 1 year; (3) Voluntary informed consent, good compliance with the study protocol, and ability to complete treatment, ultrasound evaluations, and follow-ups; (4) No contraindications to long-round needle therapy, contrast-enhanced ultrasound, or related procedures; (5) Complete clinical data without missing key information.
Exclusion criteria
Exclusion criteria: (1) History of foot trauma, fracture, or surgery within the past 3 months; (2) Comorbid foot deformities, gouty arthritis, rheumatoid arthritis, calcaneal spurs, or other organic foot disorders; (3) Severe systemic diseases such as cardiovascular/cerebrovascular diseases, hepatic/renal insufficiency, coagulation disorders, or malignant tumors; (4) Pregnant or lactating women; (5) Allergy to disinfectant materials, ultrasound contrast agents, or anesthetics; (6) Mental or cognitive impairments affecting study compliance or follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Pain Score;FFI Foot Function Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fascial Thickness;Elastic Modulus;Contrast-Enhanced Ultrasound Perfusion Parameters; | — |
Countries
People's Republic of China
Contacts
Public ContactZhang Yun
People's Liberation Army Logistics Support Force 962nd Hospital
Outcome results
None listed